Now is arguably the best of times for humankind in our three million years of evolution: precision medicine enables us to live longer and healthier and artificial intelligence (AI) addresses some of the greatest challenges to humanity.
Decades of investment in fundamental science are now bearing fruit. Immunotherapy for cancer is a reality after more than fifty years of painstaking research.
Advances in immunotherapy follow equally impressive progress in what is called precision medicine, the use of drugs that target specific mutations that drive growth in tumors. These two new treatments, combined with more traditional forms of cancer treatment including surgery, radiation therapy and chemotherapy, will extend the lives of millions of people over the coming years. There is now hope that all cancers can be effectively treated.
At the same time, advances in artificial neural networks and the advent of deep machine learning are moving the idea of artificial intelligence from the realm of science fiction to the everyday. In beating Lee Sedol, the world’s second-best player of the ancient game of Go, Google’s AlphaGo program cracked one of the longest standing and most difficult challenges in AI, confounding the expectations of even the most optimistic experts. Machines like this that don’t just compute but that learn are already transforming the way in which we diagnose disease by distinguishing minute differences in medical images of tissues of tens of thousands of patients. They will improve the efficiency electricity grids, phone systems and transport networks. And they will bring new insights into the natural world itself by helping scientists to sift.
The 20th Future Science Lecture is featuring the topics of precision medicine and AI. Invited participants include Vice Chancellor Jeffrey Lehman and professors Zhang Zheng and Steve Erlich of NYU Shanghai, Board members of Future Forum, ACCESS Health International, and Nature and Scientific American magazines. Selected investors, scientists and entrepreneurs are also invited to share their insights.
13:00-14:00 Guest Registration
14:00-14:04 Opening remarks by Ms. Cathy WU, Secretary General of the Future Forum (Hostess)
14:04-14:07 Opening remarks by Mr. Richard Zhang, Senior Partner and Head of Greater China, Apax Partners
14:07-14:10 Opening remarks by Mr. Jeffrey Lehman, vice chancellor of NYU Shanghai
14:10-14:40 Keynote Speech by Dr. William A Haseltine, Chairman and President of ACCESS Health International
The Science of Self-healing: Regenerative Medicine and Immunotherapy
14:40-15:30 Panel Discussion (in alphabetical order)
- Jenny Yao, Head of Healthcare, KPMG China (moderator)
- Ms. Mariette DiChristina, Editor-in-Chief of Scientific American
- Dr. William A. Haseltine, Chairman and President of ACCESS Health International
- Dr. Xian-Ping Lu, Co-Founder, board member, CEO and CSO ofChipscreen Biosciences
- Dr. Jiong Wu, Vice President,Fudan University Shanghai Cancer Center
- Dr. Xiaochun Xu, Director, IMM PKU-Boyalife Translational Medicine Center
16:00-16:15 Coffee Break
16:15-16:20 Opening remarks by Ms. Cathy WU, Secretary General of the Future Forum (Hostess)
The Origin of Intelligence: Review and Prospect
16:50-17:20 Keynote Speech by Dr. Kai Yu, Founder & CEO, Horizon Robotics
The Trend of AI - a Paradigm Shift of Computing
17:20-17:40 Keynote Speech by Dr. Gordon Gao, Partner of Fangda Partners
A Lawyer’s Wish for AI
17:40-18:20 Panel Discussion (in alphabetical order)
- Dr. Philip Campbell Editor-in-Chief of Natue(moderator)
- Dr. Jeffrey ERLICH, Assistant Professor of Neural Science, NYU Shanghai
- Dr. Gordon Gao, Partner of Fangda Partners
- Dr. Fei-Yue Wang, State Specially Appointed Expert&Director, the State Key Laboratory of Management and Control for Complex Systems
- Dr. Xiao-Jing WANG, Associate Vice Chancellor for Research and Global Professor of Neural Science, NYU Shanghai
- Dr. Kai Yu, Founder & CEO, Horizon Robotics
- Dr. Zheng ZHANG, Professor of Computer Science
Dr. William A. Haseltine has made significant achievements in both the science field and the business ground. In 2001, he was named by Time as one of the world's 25 most influential business people and in 2015 named to “The Worldview 100” by Scientific American Worldview as one of the top 100 “visionaries who continue to reshape biotechnology – and the world.”
A professor at Harvard Medical School and the Harvard School of Public Health from 1976 to 1992, Dr. Haseltine founded and chaired two academic research departments, the Division of Biochemical Pharmacology and the Division of Human Retrovirology, establishing himself as a pioneer in the areas of cancer, HIV/AIDS, and genomics.
Dr. Haseltine earned a BA in Chemistry from UC Berkeley in 1966 and a PhD in Biophysics from Harvard University in 1973. His postdoctoral research at the Massachusetts Institute of Technology in collaboration with several other scientists provided unexpected insights into the process of retrovirus replication and was recognized as innovative in publications in leading scientific journals.
Dr. Fei-Yue Wang received his Ph.D. in Computer and Systems Engineering from Rensselaer Polytechnic Institute, Troy, New York in 1990. He joined the Universityof Arizonain 1990 and became a Professor and Director of the Robotics and Automation Lab (RAL) and Program in Advanced Research for Complex Systems (PARCS). In 1999, he founded the Intelligent Control and Systems Engineering Center at the Institute of Automation, Chinese Academy of Sciences (CAS), Beijing, China, under the support of the Outstanding Oversea Chinese Talents Program from the State Planning Counciland “100 Talent Program” from CAS, and in 2002, was appointed as the Director of the Key Lab of Complex Systems and Intelligence Science, CAS. From 2006 to 2010, he was Vice President for research, education, and academic exchanges at the Institute of Automation, CAS. In 2011, he became the State Specially Appointed Expert and the Director of the State Key Laboratory of Management and Control for Complex Systems.Dr. Wang's current research is focused in methods and applications for parallel systems, social computing, and knowledge automation. He was the Founding Editor- in-Chief of the International Journal of Intelligent Control and Systems from 1995 to 2000, the Series on Intelligent Control and Intelligent Automation from 1996 to 2004, and IEEE Intelligent Transportation Systems from 2006 to 2008, and the EiC of IEEE Intelligent Systems from 2009 to 2012. Currently, he is the EiC of IEEE Transactions on ITS.Dr. Wang published extensively in intelligent robotic systems and automation. He is a Fellow of IEEE, INCOSE, IFAC, ASME, AAAS, and an Outstanding Scientist of ACM. He received China's Natural Science Award in 2007 and IEEE's Norbert Wiener Award in 2014.
Dr. Kai YU is the founder & CEO of Horizon Robotics Inc. He is a recognized pioneer and leader in deep learning and artificial intelligence. He was the founder and Head of Baidu Institute of Deep Learning (IDL), the first and most established artificial intelligence R&D center in China industry. During his career at Baidu, his role also included Deputy Managing Director of Baidu Research, Director of Multimedia Department, and Senior Director of Image Search Department. The teams led by Dr.Yu have won 3 Baidu Highest Achievement Awards for significant contributions to voice search, computer vision, online advertising, and web search. He has launched a number of innovation projects, including Baidu Brain, BaiduEye, Baidu Autonomous Driving, DuBike etc. Dr. Yu is elected to China “Top 1000 Talents”, a prestigious group of technology leaders of the country. Dr. Yu has published around 60 papers with more than 13000 citations. He has received many awards, including the Best Paper Runner- up Award of ICML-2013, the First Place of PASCAL VOC 2009,and the First Place of ImageNet Challenge 2010. He is an Adjunct Professor of Nanjing University, Beijing University of Posts and Telecommunications, and Institute of Computing Technology, Chinese Academy of Sciences. Before joining Baidu, he worked at Microsoft, Siemens, NEC, and was an Adjunct Faculty at Department of Computer Sciences at Stanford University. He received his B.Sc. and M.Sc. degree from Nanjing University and his Ph.D. degree from University of Munich.
Dr. Sir Philip Campbell is the Editor-in-Chief of Nature and the Editor-in-Chief of Nature- branded publications. Philip joined Nature in 1979, becoming physical sciences editor in 1982. He left Nature in 1988 to be the founding editor of Physics World. He took up his present position in December 1995. He is a Fellow of the Institute of Physics and a Fellow of the Royal Astronomical Society. Philip's first degree was in aeronautical engineering, following which he took an MSc in astrophysics at Queen Mary College London, and a PhD in upper atmospheric physics at the University of Leicester.
Mariette DiChristina is the eighth Editor-in-Chief in the 171-year history of Scientific American, and the first woman to assume the role; she is also Director of Editorial & Publishing, Magazines, for Nature Research. A science journalist for more than 20 years, she received a Folio Top Women in Media Award in 2014 and was named an American Association for the Advancement of Science Fellow in 2011 for her work in science communication. She is the Vice-Chair (2014-2016) for the Meta-Council on Emerging Technologies, part of the World Economic Forum’s Global Agenda Councils. She was also the president (in 2009 and 2010) of the 2,500-member National Association of Science Writers. She was a Visiting Scholar (in 2014 and 2015) and adjunct professor in the graduate Science, Health and Environmental Reporting program at New York University for the several years.
About Future Forum
The Future Forum is the only cross-field nonprofit platform dedicated to promoting science in China: it communicates science to the public, connects science with innovation and directs private capital to reward scientific research.
The Future Forum was established in early 2015 by a group of influential scientists, educators, entrepreneurs and investors in China. It has become a leading platform and advocate for the promotion of science with four distinct initiatives, namely the Future Science Prize, the Future Science Lectures, Think Tank Roundtable Workshops and the Future Forum Annual Conference.
About Future Science Lectures
Future Science Lectures are a monthly event open to the public, where scientists are invited to share their insights and vision and encourage dialogue with industrial experts and entrepreneurs.
For non-NYU guests, please register HERE.
For NYU guests, please register at the RSVP button below.
To our visitors
- RSVP may be required for this event. Please check event details
- Visitors will need to present a photo ID at the entrance
- There is no public parking on campus
- Entrance only through the South Lobby (1555 Century Avenue)
- Taxi card
Metro: Century Avenue Station, Metro Lines 2/4/6/9 Exit 6 in location B
Bus: Century Avenue at Pudian Road, Bus Lines 169/987